Haematology Flashcards
(213 cards)
What causes bleeding?
Under normal conditions the confinement of circulating blood to the blood vessels and maintenance of blood in a fluid state are dependent on maintaining a state of equilibrium between these processes. Loss of this balance may result in bleeding, which can be caused by:
1) Reduction in platelet number or function (primary haemostasis –platelet plug).
2) Reduction in coagulation factor(s) (secondary haemostasis – fibrin clot).
3) Increased fibrinolysis.
What are platelets?
Platelets are discoid, non-nucleated, granule-containing cells that are derived from myeloid stem cells. Platelets are formed in the bone marrow by the fragmentation of megakaryocyte cytoplasm and have a circulating lifespan of around 10 days.
How do platelets stick to damaged endothelium?
The plasma membrane contains glycoproteins (GPs) that are important for the platelet’s interactions. Following injury to the vessel wall platelets stick to the damaged endothelium, either directly to collagen via the platelet GPIa receptor or indirectly via von Willebrand factor (VWF), which binds to the platelet GPIb receptor.
What is the von Willebrand Factor (VWF)?
A glycoprotein that is synthesised by endothelial cells and megakaryocytes and circulates in plasma as multimers of different sizes. VWF mediates the adhesion of platelets to sites of injury and promotes platelet-platelet aggregation. In addition to its adhesive properties VWF is a specific carrier for factor VIII (FVIII).
What happens to platelets upon adhesion?
The adhesion of platelets causes them to become activated and changes their shape from a disc to a more rounded form with spicules to encourage platelet-platelet interaction.
What is ‘inside-out’/‘flip-flopping’?
A conformational change in the GPIIb/IIIa receptor, caused by platelet activation, to provide binding sites for fibrinogen.
What is the platelet release reaction?
The adhesion of platelets also initiates the release of the contents of their storage granules. There are two main types of ultrastructurally-identifiable granules: α-granules and dense granules. The platelet membrane is invaginated to form a surface-connected cannalicular system through which the contents of platelet granules are released.
What are the important components, of platelet granules contents, that are released?
ADP, fibrinogen and von Willebrand factor.
What is the role of fibrinogen?
Fibrinogen has a key role in linking platelets together to form the platelet plug.
What are platelets stimulated to produce, and why?
The prostaglandin - thromboxane A2 - from arachidonic acid that is derived from the cell membrane. Thromboxane A2, plays a role in platelet aggregation and is also a known vasoconstrictor and is especially important during tissue injury and inflammation.
Explain the action of antiplatelet drugs
Antiplatelet drugs are widely used for the prevention and treatment of cardiovascular and cerebrovascular disease. Aspirin and clopidogrel are the most commonly uses antiplatelet drugs:
1) Aspirin inhibits the production of thromboxane A2 by irreversibly blocking the action of cyclo-oxygenase (COX), resulting in a reduction in platelet aggregation. Although prostacyclin production is also inhibited by cyclo-oxygenase, endothelial cells can synthesise more COX whereas the non-nuclear platelet cannot. The effect of a single dose of aspirin therefore persists for around 7 days, until most of the platelets present at the time of aspirin ingestion have been replaced by new platelets.
2) Clopidogrel works by irreversibly blocking the ADP receptor (P2Y12) on the platelet cell membrane. Therefore the effect of clopidogrel ingestion also lasts for 7 days until new platelets have been produced.
What is ‘outside-in’ signalling?
Caused by fibrinogen binding to GPIIb/IIIa, which further activates the platelets.
What prevents inappropriate platelet aggregation?
The active flow of blood and the release of prostacyclin (PGI2) from endothelial cells; prostacyclin is a powerful vasodilator and suppresses platelet activation, thus preventing inappropriate platelet aggregation.
What role does positive feedback play in platelet recruitment, activation and aggregation?
The granular release of ADP and generation of thromboxane A2 have positive feedback effects resulting in further platelet recruitment activation and aggregation. They do this by binding respectively to the P2Y12 and thromboxane A2 receptor.
Describe the action of anticoagulant drugs
Anticoagulant drugs are widely used in the prevention and treatment of thrombosis. The main ones are:
1)Heparin - a mixture of glycosaminylglycan chains extracted from porcine mucosa. It works indirectly by potentiating the action of antithrombin leading to the inactivation of factors Xa and IIa (thrombin). Inactivation of thrombin requires longer chains of heparin chains, which are able to wrap around both the antithrombin and thrombin. It is administered intravenously or by subcutaneous injection. It is often used during cardiopulmonary bypass.
2) Warfarin - derived from coumarin, is a vitamin K antagonist that works by interfering with protein carboxylation. It therefore reduces synthesis of functional factors II, VII, IX and X by the liver. It is given as an oral tablet and its anticoagulant effect needs to be monitored by regular blood testing. Because it reduces synthesis of coagulation factors rather than inhibiting existing factor molecules, it takes several days to take effect.
3) Direct oral anticoagulants (DOACs) - orally available drugs that directly inhibit either thrombin or factor Xa (i.e. without the involvement of antithrombin). These do not usually require monitoring
What is prothrombin time (PT)?
It measures the integrity of the ‘extrinsic’ pathway. Blood is collected into a bottle containing sodium citrate (usually blue-topped), which chelates calcium, thus preventing the blood from clotting in the bottle
The sample is spun to produce platelet-poor plasma. A source of TF and phospholipid (usually a recombinant thromboplastin) is added to the citrated plasma sample, together with calcium to start the reaction; the length of time taken for the mixture to clot is recorded. The PT may be prolonged if there is a reduction in the activity of factors VII, X, V, II (prothrombin) or fibrinogen i.e. (‘prothrombin’ is a misnomer). When the PT is used to monitor vitamin K antagonist anticoagulant therapy such as warfarin, the results are expressed as the international normalised ratio (INR). This involves a correction for the different thromboplastin reagents used by different laboratories and means that all laboratories would be expected to obtain the same INR result for a given sample irrespective of the source of thromboplastin.
What is the activated partial thromboplastin time (APTT)?
It measures the integrity of the ‘intrinsic’ pathway. Performed by the contact activation of factor XII by a surface such as glass, or using a contact activator such as silica or kaolin. Contact activator, together with phospholipid, is added to the citrated plasma sample followed by calcium; the time taken for this mixture to clot is measured. Prolongation of the APTT is seen in a variety of situations where there is a reduction in a single or multiple clotting factors; in the the latter there may also be an associated prolonged PT. An isolated prolonged APTT (i.e. normal PT) is seen in patients with haemophilia A (factor VIII deficiency), haemophilia B (factor IX deficiency) and factor XI deficiency. However this may also be caused by factor XII deficiency which does not result in bleeding. (Note that FXII does not appear in the cell-based model described in ‘Coagulation (secondary haemostasis): formation of the stable fibrin clot’ and is not important for clotting in vivo).
What was the intrinsic-extrinsic cascade model?
An outdated model that has since been replaced by the cellular-based model. ‘Intrinsic’ refers to a system in which all components are in the plasma (factors XII, XI, IX, X and co-factors VIII and V), while the ‘extrinsic’ system comprises TF and factors VII, X, and co-factor V. It was believed that the extrinsic and intrinsic pathways ran in parallel, with initiation of the intrinsic pathway resulting from contact activation of factor XII. Through a greater understanding of factor XI and the recognition that people with inherited deficiencies of factor XII do not have bleeding problems, it became clear that the intrinsic-extrinsic model did not represent the physiological pathway of coagulation. However, the intrinsic-extrinsic model remains helpful in understanding blood tests used to assess coagulation.
What is the fibrinolytic system?
A mechanism to break down (lyse) clots. The principal fibrinolytic enzyme is plasmin, which circulates in its inactive zymogen form plasminogen. The activation of plasmin is mediated by tissue plasminogen activator (t-PA). However, t-PA does not activate plasminogen until these are both brought together by binding to lysine residues on fibrin. The breakdown of fibrin leads to the generation of fibrin-degradation produces (FDPs). Plasmin is not specific for fibrin and can also break down other protein components of plasma, including fibrinogen and the clotting factors Va and VIIIa. Plasmin is inhibited by antiplasmin which circulates in the blood.
Where are clotting factors synthesised?
Most clotting factors are synthesised in the liver. The exceptions to this are factor VIII and VWF, which are made by endothelial cells. VWF is also made in megakaryocytes and incorporated into platelet granules. Factors II (prothrombin), VII, IX and X are dependent on Vitamin K for carboxylation of their glutamic acid residues, which is essential for the function of these clotting factors. Factors V and VIII are co-factors.
What characterises each step of blood coagulation?
Each step is characterised by the conversion of an inactive zymogen (proenzyme) into an active clotting factor by the splitting of one or more peptide bones and exposure of the active enzyme site.
Where do clotting factors work and why?
Many clotting factors are believed to work on the exposed phospholipid surface of platelets, which helps to localise and accelerate these reactions.
What role do calcium ions play?
Calcium ions play an important role in the binding of activated clotting factors to the phospholipid surfaces of platelets.
What initiates coagulation?
The trigger to initiate coagulation at the site of injury is the tissue factor (TF) exposed on the surface of endothelial cells and leukocytes and on most extravascular cells in an area of tissue damage. TF is mainly located at sites that are not usually exposed to the blood under normal physiological conditions. As a result, blood only encounters TF at sites of vascular injury.